Literature DB >> 20544838

Human papillomavirus status in head and neck cancer: the ethics of disclosure.

Andrew G Shuman1, Gregory T Wolf.   

Abstract

Human papillomavirus (HPV) is an emerging causative factor for squamous carcinoma of the oropharynx and perhaps other head and neck cancers. There is a great deal of uncertainty regarding the clinical significance and implications of HPV status in this patient population. As a result, there is no established protocol for informing patients of the potential link between viral infection and their cancer. This paper discusses some of the ethical issues involved with informing head and neck cancer patients of their HPV status, recognizing the dilemma posed by unresolved clinical questions and the need to respect the autonomy of patients by disclosing relevant information.
© 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544838     DOI: 10.1002/cncr.25210

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know.

Authors:  Shrujal S Baxi; Andrew G Shuman; Geoffrey W Corner; Elyse Shuk; Eric J Sherman; Elena B Elkin; Jennifer L Hay; David G Pfister
Journal:  Head Neck       Date:  2012-11-20       Impact factor: 3.147

Review 2.  HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients.

Authors:  Max Robinson; Andrew Schache; Philip Sloan; Selvam Thavaraj
Journal:  Head Neck Pathol       Date:  2012-07-03

3.  DNMT3B C46359T and SHMT1 C1420T polymorphisms in the folate pathway in carcinogenesis of head and neck.

Authors:  Maysa Succi; Tialfi Bergamin de Castro; Ana Lívia Silva Galbiatti; Lidia Maria Rebolho Batista Arantes; Jéssika Nunes Gomes da Silva; José Victor Maniglia; Luiz Sérgio Raposo; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2013-12-22       Impact factor: 2.316

Review 4.  The "HPV Discussion": Effective Use of Data to Deliver Recommendations to Patients Impacted by HPV.

Authors:  Samir S Khariwala; Michael G Moore; Kelly M Malloy; Benoit Gosselin; Richard V Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2015-07-28       Impact factor: 3.497

Review 5.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

6.  Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.

Authors:  Rachael H Dodd; Laura A V Marlow; Jo Waller
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

7.  Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary data.

Authors:  Maggie Hendry; Diana Pasterfield; Simon Gollins; Richard Adams; Mererid Evans; Alison Fiander; Michael Robling; Christine Campbell; Marie-Jet Bekkers; Julia Hiscock; Sadia Nafees; Janice Rose; Margaret Stanley; Olwen Williams; Matthew Makin; Clare Wilkinson
Journal:  BMJ Open       Date:  2017-06-26       Impact factor: 2.692

8.  Psychosocial impact of human papillomavirus-related head and neck cancer on patients and their partners: A qualitative interview study.

Authors:  Rachael H Dodd; Alice S Forster; Laura A V Marlow; Jo Waller
Journal:  Eur J Cancer Care (Engl)       Date:  2019-01-24       Impact factor: 2.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.